Saturday 10 October 2026 Export all IDXG data to Excel Powerpack

Interpace Biosciences, Inc.

IDXG

Interpace Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.7 million, down 17.5% from fiscal 2024. In the quarter to June 2026, revenue fell 1.09%, EPS grew 104.1% and free cash flow fell 92.1%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.

6.00 0.00 0.00%

Follow IDXG

Alert me

Market cap: —
P/E: 0.2×
Fwd P/E: —
Dividend yield: —
F-score: 5/9
Altman Z: −6.95
Beneish M: 2.07
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.21	0.04	0.07	0.06
P/S ratio Full definition →		0.02	0.03	0.24	0.25
P/FCF ratio Full definition →		0.20	0.22	1.93	2.20
P/Operating CF Full definition →		0.41	0.51	30.44	92.15
P/B ratio Full definition →		0.00	0.05	0.37	0.39
Price to Tangible BV Full definition →		0.00	0.05	0.37	0.39
EV/Sales Full definition →		0.05	0.04	0.24	0.25
EV/EBITDA Full definition →		0.41	0.29	2.06	1.80
EV/Operating CF Full definition →		0.45	0.24	1.81	2.06
EV/FCF Full definition →		0.57	0.28	1.98	2.24
Quick Ratio Full definition →		1.24	1.60	2.16	1.82
Current Ratio Full definition →		1.54	1.94	2.51	2.22
Net Debt/EBITDA Full definition →		(1.04)	(1.38)	(1.96)	(4.83)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		3.21	1.59	1.51	1.54
Operating CF/Net income Full definition →		2.13	0.09	0.39	0.62
Capex/Depreciation Full definition →		(0.52)	(0.16)	(0.63)	(0.24)
Research and Development Expense of Revenue Full definition →		1.71%	1.54%	1.69%	1.63%
Selling, General and Administrative Expense of Revenue Full definition →		47.33%	46.88%	51.24%	56.76%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		0.08%	0.04%	0.04%	0.04%
Graham Net Nets Full definition →		(4.02)	(1.45)	(0.04)	(0.04)
Graham Number Full definition →		0.00	125.75	54.54	50.33
Earnings Yield Full definition →		481.81%	2,260.62%	1,381.25%	1,646.26%
Free Cash Flow Yield Full definition →		491.15%	461.73%	51.71%	45.45%
Revenue per Share Full definition →		9.89	10.43	1.98	1.65
Operating CF per Share Full definition →		2.19	2.42	0.06	0.02
Capex per Share Full definition →		(0.13)	(0.04)	(0.03)	(0.01)
Free Cash Flow per Share Full definition →		2.06	2.37	0.03	0.01
Cash per Share Full definition →		1.61	2.83	0.58	0.49
Shareholders Equity per Share Full definition →		(0.34)	25.27	5.07	4.20
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(0.34)	25.27	5.07	4.20
Free Cash Flow Full definition →		1.82	2.10	0.14	0.04
Working Capital Full definition →		3.19	4.80	6.00	6.02
Capital Expenditures Full definition →		(0.12)	(0.04)	(0.14)	(0.06)
Net Current Asset Value Full definition →		(3.20)	(1.57)	(0.36)	(0.34)
EV/EBIT Full definition →		0.49	0.35	2.61	2.20
Capex to Sales Full definition →		0.01	0.00	0.02	0.01
Price to Operating Income Full definition →		0.17	0.27	2.55	2.17
Other line items
Average Receivables Full definition →		6.63	7.10	7.35	6.77
Average Payables Full definition →		1.56	1.32	1.27	1.40
Average Assets Full definition →		13.04	24.32	23.95	23.44
Average Common Equity Full definition →		(28.99)	10.07	11.25	11.02

Fold the line items

Columns are period end dates · fundamentals updated 28 Sep 2026

Stockrow Weekly